Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, Mantle-Cell × prednylidene × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Burkitt Lymphoma 16 Prostatic Neoplasms 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Lymphoma, Large B-Cell, Diffuse 9 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8 Leukemia, Biphenotypic, Acute 3 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, B-Cell 2 Vasculitis, Central Nervous System 1 Urogenital Neoplasms 1 Stiff-Person Syndrome 1 Stage II Prostate Adenocarcinoma 1 Rasmussen subacute encephalitis 1 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1 Plasmablastic Lymphoma 1 Oropharyngeal Neoplasms 1 Opsoclonus-Myoclonus Syndrome 1 Neuromyelitis Optica 1 Myelodysplastic Syndromes 1 Myasthenia Gravis 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, T-Cell 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, AIDS-Related 1 Lymphoma 1 Lung Neoplasms 1

Interventions

Rituximab 47 Cyclophosphamide 38 ibrutinib 22 fludarabine 22 acalabrutinib 20 venetoclax 18 Bendamustine Hydrochloride 18 zanubrutinib 15 Lenalidomide 15 CT-P10 13 fludarabine phosphate 12 Cytarabine 12 pirtobrutinib 11 obinutuzumab 11 Magnetic Resonance Spectroscopy 10 Specimen Handling 9 Etoposide 9 Vincristine 8 Doxorubicin 8 Biopsy 8 glofitamab 7 Whole-Body Irradiation 7 Mycophenolic Acid 6 Methotrexate 6 Melphalan 6 Peripheral Blood Stem Cell Transplantation 5 Immunotherapy, Adoptive 5 Cyclosporine 5 orelabrutinib 4 brexucabtagene autoleucel 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02858804 2026-02-11

BDH-MCL01

Institute of Hematology & Blood Diseases Hospital, China

Phase 4 Completed

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡